Tickerplace logo

Tickerplace

VistaGen Therapeutics, Inc. logo

VTGNVistaGen Therapeutics, Inc.

VTGN Stock Price, Valuation & Chart | VistaGen Therapeutics, Inc.

Compare
$0.250+0.00 (+1.11%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyVTGN intrinsic valueVTGN calculated fair value vs price
OverviewFinancialsDividendsRatios

VTGN Historical price chart

VTGN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization10.92M
PE Ratio-0.15
EPS-1.66
Trading Volume197.79K
Today's High/Low0.25/0.25
Dividend Yield0.00
52 Week High/Low5.14/0.2
Shares Outstanding44.38M
VTGN Financial Statement
VTGN Analyst ratings
VTGN Analysis & performance metrics

VTGN Company profile

VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety,…

VTGN Management team

Management
Joshua S. Prince M.B.A.COO
Chief Operating Officer
Mark Adrian McPartland
Senior Vice President of Investor Relations
Elissa Cote
Chief Corporate Development Officer
Mark J. Ginski Ph.D.
Senior Vice President and Head of Chemistry, Manufacturing & Controls
Shawn K. Singh J.D.CEO
President, Chief Executive Officer & Director
Mark Flather
Senior Vice President of Corporate Strategy & Capital Markets
Michelle Peters Wellington
Vice President of Communications
Trisha Fitzmaurice
Senior Vice President of Human Resources
Total 8 executives

VTGN Frequently asked questions

What is VistaGen Therapeutics, Inc. (VTGN) Stock Price?

Current stock price of VistaGen Therapeutics, Inc. (VTGN) stock is $0.250. The stock price is +1.11% higher in the session. The intraday range can be seen from this page. Volume of VistaGen Therapeutics, Inc. (VTGN) stock is 197.79K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the VistaGen Therapeutics, Inc. (VTGN) stock price going up or down today?

The stock price of VistaGen Therapeutics, Inc. (VTGN) can change with earnings, company news, and overall market sentiment. VistaGen Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the VistaGen Therapeutics, Inc. stock expensive at its current price?

Whether VistaGen Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VTGN on this page is -0.15. EPS on this page is -1.66. Compare those figures with peers and growth expectations before deciding if the current VistaGen Therapeutics, Inc. price is justified.

How has the stock price of VistaGen Therapeutics, Inc. (VTGN) performed historically?

Historical performance for VistaGen Therapeutics, Inc. (VTGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VTGN reacted to past earnings and market events.

Should I buy VistaGen Therapeutics, Inc. (VTGN) stock, at this price?

Buying VistaGen Therapeutics, Inc. (VTGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.